Nashville, Tennessee


Purpose:

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.


Criteria:

Inclusion criteria - Pathologically-proven diagnosis of melanoma. - Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible. Exclusion criteria - Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol. - Any patient unable or unwilling to provide consent.


NCT ID:

NCT01205815


Primary Contact:

Principal Investigator
Jeffrey Sosman, M.D.
Vanderbilt-Ingram Cancer Center

VICC Clinical Trials Information Program, RN
Phone: 800-811-8480


Backup Contact:

N/A


Location Contact:

Nashville, Tennessee
United States

VICC Clinical Trials Information Program, M.D.
Phone: 800-811-8480

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.